Travel grant (2025), Singapore, Asia Bio, September 8-10. Swedish Biotech and Medtech Delegation to Singapore

Important results from the project

The project met its objectives, including strengthening our presence in APAC via participation in Asia Bio as part of a delegation. We established new connections with key stakeholders in the local life science ecosystem. By showcasing Salipro® in a regional context, we increased our visibility and laid the foundation for future collaborations. The project also provided strategic insights that support our long-term growth and contribute to Sweden’s global positioning in life science innovation.

Expected long term effects

In the long term, the project is expected to strengthen Salipro Biotech’s position in the APAC region through new strategic relationships, particularly in Singapore. These may evolve into co-development or licensing opportunities around the Salipro® platform. The outcomes support our global expansion and reinforce Sweden’s role in advancing life science innovation through international collaboration, and networking.

Approach and implementation

The project followed the original plan, focusing on strategic outreach in Singapore. Our participation in Asia Bio 2025 as part of a delegation enabled direct engagement with key stakeholders through partnering meetings, networking events, and site visits. Salipro® was introduced to a targeted audience, generating new leads. Activities were carried out as planned, and contributed to Salipro’s regional expansion strategy and also reinforced Sweden’s position as a leader in biotech innovation.